Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06874231

Brain Connectivity Marker for Alzheimer's Disease

Clinical Application of a Brain Connectivity Marker for Early Detection of Alzheimer's Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Karolinska Institutet · Academic / Other
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Accepted

Summary

The main purpose of this project is to establish whether changes in brain connectivity can be used to predict the development of Alzheimer's disease (AD).

Detailed description

To achieve this aim, the investigators will perform six different studies that have been designed to achieve the following specific objectives: 1.1. Identify changes of brain connectivity in individuals who show abnormal AD amyloid biomarkers in the cerebrospinal fluid and blood. 1.2. To assess the correlation between brain connectivity changes and biomarkers of synaptic dysfunction and inflammation as well as alterations of electrical brain signals. 1.3. Establish whether alterations of brain connectivity could be improved after patients start treatment with cholinesterase inhibitors. 1.4. Assess differences in brain connectivity between patients receiving treatment with statins and those not taking this medication. 1.5. Determine whether brain connectivity changes can predict longitudinal cognitive decline and conversion to AD dementia. 1.6. Assess whether different microorganisms can grow more rapidly in the cerebrospinal fluid from AD patients compared to controls and whether their levels are associated with brain connectivity. 1.7. Evaluate the relationship between brain connectivity and the integrity of the locus coeruleus, which is the earliest site of AD pathology

Conditions

Interventions

TypeNameDescription
OTHERNeuroimagingThe investigators will collect imaging sequence, cognitive test scores, clinical data and biofluid samples

Timeline

Start date
2023-04-01
Primary completion
2027-07-31
Completion
2027-07-31
First posted
2025-03-13
Last updated
2025-03-17

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT06874231. Inclusion in this directory is not an endorsement.